| P2093 | author name string | A. Christofides | |
| | C. Owen | |
| | C. Toze | |
| P2860 | cites work | Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study | Q33428297 |
| | Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study | Q33432228 |
| | Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study | Q33438428 |
| | Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL. | Q33794311 |
| | Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial | Q34141305 |
| | Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia | Q34402999 |
| | Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia | Q35958056 |
| | Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective | Q38594805 |
| | Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial | Q39005118 |
| | Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia | Q39013886 |
| | First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority tri | Q40662825 |
| | Venetoclax for the treatment of chronic lymphocytic leukemia. | Q47875923 |
| | Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions | Q56657194 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 91-103 | |
| P577 | publication date | 2018-02-28 | |
| P1433 | published in | Current Oncology | Q3498968 |
| P1476 | title | Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in untreated chronic lymphocytic leukemia | |
| P478 | volume | 25 | |